Amedisys ROE 2010-2025 | AMED
Current and historical return on equity (ROE) values for Amedisys (AMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Amedisys ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2025-03-31 |
$0.09B |
$1.25B |
7.49% |
| 2024-12-31 |
$0.04B |
$1.18B |
3.66% |
| 2024-09-30 |
$0.08B |
$1.20B |
7.07% |
| 2024-06-30 |
$0.09B |
$1.18B |
8.02% |
| 2024-03-31 |
$-0.02B |
$1.14B |
-1.90% |
| 2023-12-31 |
$-0.01B |
$1.12B |
-0.91% |
| 2023-09-30 |
$0.00B |
$1.09B |
0.27% |
| 2023-06-30 |
$0.00B |
$1.06B |
0.27% |
| 2023-03-31 |
$0.11B |
$1.13B |
10.39% |
| 2022-12-31 |
$0.12B |
$1.11B |
11.33% |
| 2022-09-30 |
$0.12B |
$1.07B |
11.89% |
| 2022-06-30 |
$0.14B |
$1.04B |
14.15% |
| 2022-03-31 |
$0.19B |
$1.02B |
19.99% |
| 2021-12-31 |
$0.21B |
$0.98B |
23.28% |
| 2021-09-30 |
$0.22B |
$0.95B |
25.69% |
| 2021-06-30 |
$0.25B |
$0.88B |
30.54% |
| 2021-03-31 |
$0.20B |
$0.79B |
26.23% |
| 2020-12-31 |
$0.18B |
$0.81B |
24.77% |
| 2020-09-30 |
$0.17B |
$0.76B |
23.84% |
| 2020-06-30 |
$0.13B |
$0.72B |
19.49% |
| 2020-03-31 |
$0.13B |
$0.68B |
20.58% |
| 2019-12-31 |
$0.13B |
$0.64B |
21.81% |
| 2019-09-30 |
$0.13B |
$0.60B |
23.23% |
| 2019-06-30 |
$0.12B |
$0.56B |
24.45% |
| 2019-03-31 |
$0.12B |
$0.52B |
26.26% |
| 2018-12-31 |
$0.12B |
$0.48B |
25.01% |
| 2018-09-30 |
$0.09B |
$0.45B |
18.13% |
| 2018-06-30 |
$0.07B |
$0.41B |
14.29% |
| 2018-03-31 |
$0.04B |
$0.55B |
8.11% |
| 2017-12-31 |
$0.03B |
$0.52B |
5.99% |
| 2017-09-30 |
$0.04B |
$0.51B |
8.82% |
| 2017-06-30 |
$0.04B |
$0.49B |
8.28% |
| 2017-03-31 |
$0.05B |
$0.48B |
10.12% |
| 2016-12-31 |
$0.04B |
$0.46B |
8.48% |
| 2016-09-30 |
$0.04B |
$0.45B |
9.68% |
| 2016-06-30 |
$0.04B |
$0.43B |
9.25% |
| 2016-03-31 |
$0.04B |
$0.41B |
9.53% |
| 2015-12-31 |
$0.00B |
$0.41B |
-0.77% |
| 2015-09-30 |
$-0.01B |
$0.39B |
-1.82% |
| 2015-06-30 |
$-0.01B |
$0.38B |
-1.83% |
| 2015-03-31 |
$-0.01B |
$0.37B |
-2.63% |
| 2014-12-31 |
$0.01B |
$0.40B |
3.43% |
| 2014-09-30 |
$-0.01B |
$0.38B |
-1.61% |
| 2014-06-30 |
$-0.11B |
$0.37B |
-28.30% |
| 2014-03-31 |
$-0.11B |
$0.36B |
-28.14% |
| 2013-12-31 |
$-0.10B |
$0.37B |
-22.90% |
| 2013-09-30 |
$-0.19B |
$0.38B |
-43.89% |
| 2013-06-30 |
$-0.09B |
$0.47B |
-18.84% |
| 2013-03-31 |
$-0.09B |
$0.46B |
-16.95% |
| 2012-12-31 |
$-0.08B |
$0.45B |
-16.02% |
| 2012-09-30 |
$0.03B |
$0.57B |
4.99% |
| 2012-06-30 |
$-0.41B |
$0.54B |
-77.41% |
| 2012-03-31 |
$-0.39B |
$0.53B |
-63.08% |
| 2011-12-31 |
$-0.38B |
$0.52B |
-53.45% |
| 2011-09-30 |
$-0.37B |
$0.51B |
-45.26% |
| 2011-06-30 |
$0.08B |
$0.93B |
9.10% |
| 2011-03-31 |
$0.09B |
$0.90B |
10.52% |
| 2010-12-31 |
$0.11B |
$0.88B |
13.53% |
| 2010-09-30 |
$0.13B |
$0.85B |
16.15% |
| 2010-06-30 |
$0.14B |
$0.83B |
18.85% |
| 2010-03-31 |
$0.15B |
$0.78B |
20.50% |
| 2009-12-31 |
$0.14B |
$0.74B |
20.43% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.081B |
$2.348B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
